Sign in

Ilaria Cherchi

@ilariache.bsky.social
36 followers 61 following 6 posts

PhD candidate @ University of Trento (CIBIO) - Laboratory of Computational and Functional Oncology 🧬 Telomeres in cancer | cancer genomics | liquid biopsy | computational biology

PostsRepliesMedia
Reposted by Ilaria Cherchi
Korbel Group @ EMBL @korbel-group-embl.bsky.social · 16/03/2026
🎉 Congratulations to Ilaria Cherchi (@ilariache.bsky.social) for securing an EMBO Scientific Exchange Grant! Ilaria is a visiting PhD student from the Demichelis Lab at the University of Trento, and she is currently exploring the contribution of telomeric dysregulation (1/2)
151
Reposted by Ilaria Cherchi
Korbel Group @ EMBL @korbel-group-embl.bsky.social · 11/02/2026
Celebrating the women and the gender-diversity in our lab today, and every day! 🎉 Happy International Day of Women and Girls in Science! #WomenInScience #WomenInSTEM #IDWGS
021
Ilaria Cherchi @ilariache.bsky.social · 16/01/2026
Does changing the reference genome from hg38 to T2T-CHM13 affect mapping over clinically relevant variants?   📄 To find out check our new preprint at doi.org/10.64898/202...   DemichelisLab (@Francesca Demichelis) @UniTrento CIBIO (Università di Trento) @yariciani.bsky.social
doi.org
T2T-CHM13 reference genome reduces mapping bias and enhances alignment accuracy at disease-associated variants
The T2T-CHM13v2.0 reference genome added previously uncharacterized genomic sequences and improved the accuracy of repetitive stretches compared to former human genome assemblies. By comprehensive allelic variation analysis and read mapping statistics from sequencing reads aligned to hg38 and T2T-CHM13 assemblies in samples encompassing different sequencing designs and ethnicity groups, we observed that T2T-CHM13v2.0 assembly significantly reduces the reference mapping bias (RMB) and increases read mapping precision at clinically relevant sites, including BRCA1 pathogenic variants. Further, we report the presence of sequence dissimilarities among reference genomes in the proximity of ClinVar annotated variants, suggesting the need for data re-analysis and potential redesign of probes targeting clinically relevant regions. Overall, these findings support the implementation of T2T-CHM13 reference for the improvement of sequencing data analyses in the clinical genomic setting. ### Competing Interest Statement The authors have declared no competing interest. Fondazione AIRC per la ricerca sul cancro, IT, 22792 Fondazione Cassa Di Risparmio Di Trento E Rovereto, IT Cancer Research UK, https://ror.org/054225q67, A26822 Department of CIBIO – University of Trento
112
Reposted by Ilaria Cherchi
The Rockefeller University @rockefeller.edu · 31/07/2025
Catch up on the latest chromosome news from The Scientist, including work from our own Titia de Lange! Recent work found that DNA's well-known end replication problem is more complex than we thought, with telomerase providing only part of the solution.
the-scientist.com
Chromosomes in Focus: Origins, Genes, and Cancer
In the 150 years since chromosomes were first discovered, scientists have studied them in various contexts, from insect cells to artificial systems.
041
Reposted by Ilaria Cherchi
Aleena M Stolworthy @aleenamolbio.bsky.social · 24/05/2025
Time to modernise the human reference genome. Karen Miga @humanpangenome.bsky.social on how T2T assemblies open new biological discoveries. Still one genome cannot represent our genetics diversity, No matter how complete. Incredibly exciting for the global community. #ESHG2025
077
Ilaria Cherchi @ilariache.bsky.social · 16/05/2025
Looking forward to attending #eshg2025 🧬 I will present my poster on the benefits of #T2T reference genome for SNP calling and identification of clinically relevant variants. Let’s meet in Milan!
082